Company profile: Epistem
1.1 - Company Overview
Company description
- Provider of specialist contract research services supporting drug discovery and development, offering preclinical in vitro/in vivo models in oncology, inflammatory and gastrointestinal diseases (incl. GI toxicities); GCLP-accredited clinical trial support (histology, IHC, image analysis, gene expression, DNA genotyping); organoid models; cancer stem cell sphere assays; subcutaneous xenografts; orthotopic/metastatic bioluminescent models.
Products and services
- Clinical Trial Support: Delivers histology, IHC, image analysis, gene expression, and DNA genotyping in GCLP-accredited laboratories, supporting drug discovery and development pipelines
- Organoid Models: Offers custom protocol-supported organoid models for complex physiological systems and disease modeling, aiding drug discovery and development pipelines
- Preclinical Services: Engineers in vitro and in vivo models focusing on oncology, inflammatory diseases, and gastrointestinal disease areas, including GI toxicities, to support drug discovery and development pipelines
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Epistem
IMGM Laboratories
HQ: Germany
Website
- Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMGM Laboratories company profile →
Linkage Biosciences
HQ: United States
Website
- Description: Provider of molecular diagnostic products that improve and expedite complex genetic testing, initially focused on diagnostic products for solid organ and hematopoietic stem cell transplantation, including human leukocyte antigen testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Linkage Biosciences company profile →
Qiagen
HQ: The Netherlands
Website
- Description: Provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. Supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics, with sample and assay consumables offered in kit form. Portfolio includes automated nucleic acid purification systems, sample disruption tools, real-time and digital PCR platforms, and automated PCR setup.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qiagen company profile →
4basebio
HQ: Germany
Website
- Description: Provider of DNA manufacturing technologies and products for the gene therapy market, including double-stranded DNA formats: hpDNA (hairpinned ends for viral and non-viral vectors), osDNA (with nucleotide modifications for degradation resistance and tunable immunostimulation for DNA vaccines), opDNA and oeDNA for mRNA production and genome editing, the Hermes non-viral delivery platform, and DNA template manufacturing for AAV/Lentivirus with small-scale AAV production and purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4basebio company profile →
BioTeam
HQ: United States
Website
- Description: Provider of technology-based consulting services for organizations and enterprises.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioTeam company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Epistem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Epistem
2.2 - Growth funds investing in similar companies to Epistem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Epistem
4.2 - Public trading comparable groups for Epistem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →